Arch Neurol

• 

  Publication Venue For

  • Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort..  69:246-250. 2012
  • Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease..  68:1404-1411. 2011
  • Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial..  68:1245-1251. 2011
  • Risk factors and preventive interventions for Alzheimer disease: state of the science..  68:1185-1190. 2011
  • Statins after intracerebral hemorrhage: to treat or not to treat..  68:565-566. 2011
  • Racial and socioeconomic disparities in parkinsonism..  68:498-503. 2011
  • Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors..  68:329-337. 2011
  • Hearing loss and incident dementia..  68:214-220. 2011
  • In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults..  68:232-240. 2011
  • Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment..  68:113-119. 2011
  • Validation of consensus panel diagnosis in dementia..  67:1506-1512. 2010
  • Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative..  67:1370-1378. 2010
  • Retinopathy and lobar intracerebral hemorrhage: insights into pathogenesis..  67:1224-1230. 2010
  • Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study..  66:1378-1383. 2009
  • Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up..  65:727-732. 2008